148 related articles for article (PubMed ID: 18205596)
1. A shift in the use of drug-eluting stents in Australian private hospitals.
McLean SM; Clark DJ
Med J Aust; 2008 Jan; 188(2):127. PubMed ID: 18205596
[No Abstract] [Full Text] [Related]
2. Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?
Latib A; Chieffo A; Colombo A
Monaldi Arch Chest Dis; 2007 Mar; 68(1):1-5. PubMed ID: 17564287
[No Abstract] [Full Text] [Related]
3. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely.
Colombo A; Gerber RT
Circ Cardiovasc Interv; 2008 Dec; 1(3):226-32. PubMed ID: 20031682
[No Abstract] [Full Text] [Related]
4. Is implantation of drug-eluting stents a Faustian choice?
Brener SJ
J Invasive Cardiol; 2010 Oct; 22(10):465-6. PubMed ID: 20944184
[No Abstract] [Full Text] [Related]
5. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
[TBL] [Abstract][Full Text] [Related]
6. Resistance to what, does it matter? How do we study it?
Holmes DR
Eur Heart J; 2008 Apr; 29(8):957-8. PubMed ID: 18346961
[No Abstract] [Full Text] [Related]
7. Drug-eluting coronary stents: as safe as bare-metal stents, but optimized antiplatelet therapy may further improve clinical outcome.
Trenk D; Neumann FJ
Eur J Clin Pharmacol; 2008 Mar; 64(3):227-32. PubMed ID: 18075736
[No Abstract] [Full Text] [Related]
8. [A friend in need is a friend indeed: the case of drug-eluting stents, diabetes and small vessel size].
Kastrati A; Elezi S; Schömig A
Rev Esp Cardiol; 2006 Oct; 59(10):991-3. PubMed ID: 17125706
[No Abstract] [Full Text] [Related]
9. Retrograde embolization after balloon angioplasty in a patient with late stent subthrombosis in a paclitaxel-eluting stent.
De Wolf A; Basoglu A; Vranckx P; Benit E
Acta Cardiol; 2008 Dec; 63(6):797-9. PubMed ID: 19157178
[TBL] [Abstract][Full Text] [Related]
10. Very late thrombosis of paclitaxel-eluting stent.
Aytekin V; Erdim R; Gormez S; Demiroglu C
Cardiovasc Revasc Med; 2008; 9(4):275-7. PubMed ID: 18928954
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-eluting coronary stents.
Ajani AE; Waksman R
N Engl J Med; 2004 May; 350(20):2099-100; author reply 2099-100. PubMed ID: 15141053
[No Abstract] [Full Text] [Related]
12. [Results of using the resolute stent in everyday clinical practice in 5000 patients].
Savchenko AP; Rudenko AP; Cherkavskaia OV
Vestn Rentgenol Radiol; 2010; (4):43-7. PubMed ID: 22187910
[No Abstract] [Full Text] [Related]
13. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S
Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
15. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
16. Simultaneous late stent thrombosis of drug-eluting stents causing acute anterior and inferior myocardial infarction.
Arora N; Aggarwal K
J Invasive Cardiol; 2008 Jan; 20(1):E14-7. PubMed ID: 18174623
[No Abstract] [Full Text] [Related]
17. Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.
Gao Z; Xu B; Yang Y; Chen J; Qiao S; Li JJ; Qin X; Wu Y; Yao M; Yuan J; Chen J; Liu H; Dai J; Gao RL
J Interv Cardiol; 2010 Aug; 23(4):346-51. PubMed ID: 20718906
[TBL] [Abstract][Full Text] [Related]
18. [Surgical risk of the patients treated with DES and dual anti-platelet therapy].
Nanto S
Masui; 2010 Nov; 59 Suppl():S1-7. PubMed ID: 21688454
[No Abstract] [Full Text] [Related]
19. Perioperative antiplatelet therapy in patients with coronary stents.
Cohen E; Osherov AB; Edry R; Sebbag A; Massalha S; Kerner A; Roguin A
Int J Cardiol; 2010 Dec; 145(3):548-50. PubMed ID: 20554064
[No Abstract] [Full Text] [Related]
20. Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Jang SW; Kim DB; Kwon BJ; Shin D; Her SH; Park CS; Park HJ; Park MW; Cho EJ; Rho TH; Kim JH
Int J Cardiol; 2010 Apr; 140(1):e8-11. PubMed ID: 19117624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
